Cigarette smoke decreases salivary 18 kDa translocator protein binding affinity - in association with oxidative stress

Current Medicinal Chemistry

Volumn 17, Issue 23, 2010, Pages 2539-2546

  Nagler, R ^a   Savulescu, D ^a   Krayzler, Ella ^a   Leschiner, S ^a   Veenman, L ^a   Gavish, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

18 kDa Translocator protein (TSPO); Cigarette smoke; oxidative stress; peripheral type benzodiazepine receptor (PBR); saliva

Indexed keywords

CARRIER PROTEIN; CIGARETTE SMOKE; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CELL FRACTIONATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOUTH CANCER; MOUTH MUCOSA; MUCOSA CELL; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN BINDING; SALIVA ANALYSIS;

ADULT; AGED; CELL SURVIVAL; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN BINDING; RECEPTORS, GABA; SALIVA; SMOKING; YOUNG ADULT;

EID: 77955632587     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791556050     Document Type: Article

References (56)

1. Papadopoulos, V; Baraldi, M.; Guilarte, T.R.; Knudsen, T.B.; Lacapère, J.J.; Lindemann, P.; Norenberg, M.D.; Nutt, D.; Weizman, A.; Zhang, M.R.; Gavish, M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functions. Trends. Pharmacol. Sci. 2006, 27, 402-9.
2. Veenman, L.; Papadopoulos, V.; Gavish, M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des. 2007, 13, 2385-405.
3. Anholt, R.R.; Pedersen, P.L.; De Souza, E.B.; Snyder, S.H. The peripheral-type benzodiazepine receptor: Localization to the mitochondrial outer membrane. J. Biol. Chem. 1986, 261, 576-83.
4. Gavish, M.; Bachman, I.; Shoukrun, R.; Katz, Y.; Veenman, L.; Weisinger, G.; Weizman, A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 1999, 51, 629-50.
5. Papadopoulos, V.; Mukhin, A.G.; Costa, E.; Krueger, K.E. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 1990, 265, 3772-9.
6. Zavala, F.; Lenfant, M. Peripheral benzodiazepines enhance the respiratory burst of macrophage-like P388D1 cells stimulated by arachidonic acid. Int. J. Immunopharmacol. 1987, 9, 269-74.
7. Hirsch, J.D.; Beyer, C.F.; Malkowitz, L.; Beer, B.; Blume, A.J. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol. Pharmacol. 1989, 1, 157-3.
8. Veenman, L.; Gavish, M. The peripheral-type benzodiazepine receptor and the cardiovascular system: implications for drug development. Pharmacol. Therap. 2006, 110, 503-24.
9. van Kammen, D.P.; Guidotti A.; Neylan T.; Guaneri, P.; Kelley, E.; Gurklis, E.; Gilbertson, M.W.; Peters, J.L.; Costa, E. CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships. Biol. Psychiatry. 1993, 34, 515-22.
10. Levin, E.; Premkumar, A.; Veenman, L.; Kugler, W.; Leschiner, S.; Spanier, I.; Weisinger, G.; Lakomek, M.; Weizman, A.; Snyder, S.H.; Pasternak, G.W.; Gavish, M. The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein [IBP] antisense knockdown in the C6 glioma cell line. Biochemistry 2005, 44, 9924-35.
11. Kugler, W.; Veenman, L.; Shandalov, Y.; Leschiner, S.; Spanier, I.; Lakomek, M.; Gavish, M. Ligands of the mitochondrial 18 kDa Translocator Protein attenuate apoptosis in human glioblastoma cells exposed to erucylphosphohomocholine. Cell. Oncol. 2008, 30, 435-50.
12. Shoukrun, R.; Veenman, L.; Shandalov, Y.; Leschiner, S.; Spanier, I.; Karry, R.; Katz, Y.; Weisinger, G.; Weizman, A.; Gavish, M. The 18 kDa Translocator Protein, formerly known as the peripheral- type benzodiazepine receptor, confers pro-apoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet. Genomics 2008, 18, 977-88.
13. Veenman, L.; Shandalov, Y.; and Gavish, M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr. 2008, 40, 199-205.
14. Veenman, L.; Weizman, A.; Weisinger, G.; Gavish, M. Expression and functions of the 18 kDa Mitochondrial Translocator Protein (TSPO) in Health and Disease. Targeted Drug Delivery in Cancer Therapeutics 2009, in press.
15. Zeno, S.; Zaaroor, M.; Leschiner, S.; Veenman, L.; Gavish, M. CoCl[2] induces apoptosis via the 18kDa Translocator Protein in U118MG human glioblastoma cells. Biochem. 2009, 48, 4652-61.
16. Wang, J.K.; Morgan, J.I.; Spector, S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. U S A 1984, 81, 753-6.
17. Carmel, I.; Fares, F.; Leschiner, S.; Scherübl, H.; Weisinger, G.; Gavish, M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem. Pharmacol. 1999, 58, 273-8.
18. Katz, Y.; Ben-Baruch, G.; Kloog, Y.; Menczer, J.; Gavish, M. Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. 1990, 78, 155-8.
19. Han, Z.; Slack, R.S.; Li, W.; Papadopoulos, V. Expression of peripheral benzodiazepine receptor [PBR] in human tumors: relationship to breast, colorectal, and prostate tumor progression. J. Recept. Signal. Transduct. Res. 2003, 23, 225-38.
20. Galiègue, S.; Casellas, P.; Kramar, A.; Tinel, N.; Simony-Lafontaine, J. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin. Cancer Res. 2004, 10, 2058-64.
21. Veenman, L.; Levin, E.; Weisinger, G.; Leschiner, S.; Spanier, I.; Snyder, S.H.; Weizman, A.; Gavish, M. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem. Pharmacol. 2004, 68, 689-98.
22. Hardwick, M.J.; Chen, M.K.; Baidoo, K.; Pomper, M.G.; Guilarte, T.R. In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: a biomarker for inflammation. Mol. Imaging 2005, 4, 432-8.
23. Torres, S.R.; Fröde, T.S.; Nardi, G.M.; Vita, N.; Reeb, R.; Ferrara, P.; Ribeiro-do-Valle, R.M.; Farges, R.C. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur. J. Pharmacol. 2000, 408, 199-211.
24. Farges, R.C.; Torres, S.R.; Ferrara, P.; Ribeiro-do-Valle, R.M. Involvement of steroids in anti-inflammatory effects of peripheral benzodiazepine receptor ligands. Life Sci. 2004, 74, 1387-95.
25. Hershkovich, O.; Oliva, J.; Nagler, R.M. Lethal synergistic effect of cigarette smoke and saliva in an in vitro model: does saliva have a role in the development of oral cancer? Eur. J. Cancer 2004, 40, 1760-7.
26. Hershkovich, O.; Reznick, A.Z.; and Nagler, R.M. Saliva - a pivotal player in the pathogenesis of oropharyngeal cancer. Br. J. Cancer 2004, 91, 111-8.
27. Hasnis, E.; Reznick, A.Z.; Pollack, S.; Klein, Y.; Nagler, R.M. Synergistic effect of cigarette smoke and saliva on lymphocytes - the mediatory role of volatile aldehydes and redox active iron and the possible implications for oral cancer. I.J.B.C.B. 2004, 36, 826- 39.
28. Bahar, G.; Feinmesser, R.; Shpitzer, T.; Popovtzer, A.; Nagler, R.M. Salivary analysis in oral cancer patients: reactive nitrogen species, and antioxidant profile. Cancer 2007, 109, 54-9.
29. Datta, K.; Sinha, S.; Chattopadhyay, P. Reactive oxygen species in health and disease. Natl Med J India. 2000, 13, 304-10.
30. Hecht, S.S. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks. Arch. Surg. 2006, 391, 603-13.
31. Delavoie, F.; Li, H.; Hardwick, M.; Robert, J.; Giatzakis, C.; Peranzi, G.; Maccario, J.; Lacapere, J.; Papadopoulos, V. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochem. 2003, 42, 4506-19.
32. Nagler, R.M.; Lischinsky, S.; Diamond, E.; Klein, I.; Reznick, A.Z. New insights into salivary lactate dehydrogenase of human subjects. J. Lab. Clin. Med. 2001, 137, 363-9.
33. Bremmer, J.F.; Graveland, A.P.; Brink, A.; Braakhuis, B.J.; Kuik, D.J.; Leemans, C.R.; Bloemena, E.; van der Waal, I.; Brakenhoff, R.H. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev. Res. (Phila Pa). 2009, 2, 128-33.
34. Upile, T.; Jerjes, W.; Kafas, P.; Harini, S.; Singh, S.U.; Guyer, M.; Bentley, M.; Sudhoff, H.; Hopper, C. Salivary VEGF: a noninvasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication. Int. Arch. Med. 2009, 2, 12.
35. Tan, W.; Sabet, L.; Li, Y.; Yu, T.; Klokkevold, P.R.; Wong, D.T.; Ho, C.M. Optical protein sensor for detecting cancer markers in saliva. Biosens. Bioelectron. 2008, 24, 266-71.
36. Hallare, A.V.; Gervasio, M.K.; Gervasio, P.L.; Acacio-Claro, P.J. Monitoring genotoxicity among gasoline station attendants and traffic enforcers in the City of Manila using the micronucleus assay with exfoliated epithelial cells. Environ. Monit. Assess. 2009, 156, 331-41.
37. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 1976, 72, 248-4.
38. Fares, F.; and Gavish, M. Characterization of peripheral benzodiazepine binding sites in human term placenta. Biochem. Pharmacol. 1986. 35, 227-30.
39. Veenman, L.; Leschiner, S.; Spanier, I.; Weisinger, G.; Weizman, A.; Gavish, M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J. Neurochem. 2002, 80, 917- 27.
40. McEnery, M.W.; Snowman, A.M.; Trifiletti, R.R.; Snyder, S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA 1992, 89, 3170-4.
41. Melamed, D.; Miri, E.; Leider, N; Nemazee, D. Unexpected autoantibody production in membrane Ig-m-Deficient/lpr mice. J. Immunol. 2000, 165, 4353-8.
42. Levine, R.L.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Carbonyl assays for determination of oxidatively modified proteins. Methods. Enzymol. 1994, 233, 346-57.
43. Buss, H.; Chant, P.; Sluis, K.B.; Domigan, N.M.; Winterbourne, C.C. Protein carbonyl measurement by a sensitive ELISA method. Free Rad. Biol. Med. 1997, 23, 361-66.
44. Inder, T.; Mocatta, T.; Darlow, B.; Spencer, C.; Volpe, J.J.; Winterbourne, C. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Ped. Res. 2002, 52, 213-8.
45. Buege, J.A.; Aust, S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52, 302-10.
46. Awad, M.; Gavish, M. Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon. Life Sci. 1991, 49, 1155- 61.
47. Rao, V.L.; Butterworth, R.F. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. Eur. J. Pharmacol. 1997, 340, 89-99.
48. Camins, A.; Sureda, F.X.; Pubill, D.; Camarasa, J.; Escubedo, E. Characterization and differentiation of peripheral-type benzodiazepine receptors in rat and human prostate. Life Sci. 1994, 54, 759-67.
49. Valtier, D.; Malgouris, C.; Gilbert, J.C.; Guicheney, P.; Uzan, A.; Gueremy, C.; Le Fur G.; Saraux, H.; Meyer, P. Binding sites for a peripheral type benzodiazepine antagonist ([3H]PK 11195) in human iris. Neuropharmacology. 1987, 26, 6549-52.
50. Yanbaeva, D.G.; Dentener, M.A.; Cruetzberg, E.C.; Wesseling, G.; Wouters, E.F. Systemic effects of smoking. Chest 2007, 134, 1557- 66.
51. Casellas, P.; Galiegue, S.; Basile, A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Internat. 2002, 40, 475-6.
52. Stoebner, P.E.; Carayon, P.; Casellas, P.; Portier, M.; Lavabre- Bertrand, T.; Cuq, P.; Cano, J-P.; Meynadier, J.; Meunier, L. Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis. Cell Death Diff. 2001, 8, 747-53.
53. Carayon, P.; Portier, M.; Dussossoy, D.; Bord, A.; Petitpretre, G.; Canat, X.; Le Fur, G.; Casellas, P. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 1996, 87, 3170-8.
54. Ruff, M.R.; Pert, C.B.; Weber, R.J.; Wahl, L.M.; Wahl, S.M.; Paul, S.M. Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science 1985, 229, 1281-3.
55. Bessler, H.; Caspi, B.; Gavish, M.; Rehavi, M.; Hart, J.; Weizman, R. Peripheral-type benzodiazepine receptor ligands modulate human natural killer cell activity. Int. J. Immunopharmacol. 1997, 19, 249-54.
56. Numabe, Y.; Ogawa, T.; Kamoi, H.; Kiyonobu, K.; Sato, S.; Kamoi, K.; Deguchi, S. Phagocytic function of salivary PMN after smoking or secondary smoking. Ann. Periodontol. 1998, 3, 102-7.